A phase II trial of lenvatinib plus toripalimab and hepatic arterial infusion chemotherapy as a first-line treatment for advanced hepatocellular carcinoma (LTHAIC study).

被引：20
|
作者：
He, MinKe [1 ]
Ming, Shi [1 ]
Lai, Zhicheng [1 ]
Li, QiJiong [1 ]
机构：
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Hepatobiliary Oncol,Canc Ctr, Guangzhou, VA, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4083
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma
    He, Min-Ke
    Liang, Run-Bin
    Zhao, Yang
    Xu, Yu-Jie
    Chen, Huan-Wei
    Zhou, Yuan-Min
    Lai, Zhi-Cheng
    Xu, Li
    Wei, Wei
    Zhang, Yao-Jun
    Chen, Min-Shan
    Guo, Rong-Ping
    Li, Qi-Jiong
    Shi, Ming
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [2] Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial
    Lai, ZhiCheng
    He, MinKe
    Bu, XiaoYun
    Xu, YuJie
    Huang, YeXing
    Wen, DongSheng
    Li, QiJiong
    Xu, Li
    Zhang, YaoJun
    Wei, Wei
    Chen, MinShan
    Kan, Anna
    Shi, Ming
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : 68 - 77
  • [3] Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma
    Xu, Yu-Jie
    Lai, Zhi-Cheng
    He, Min-Ke
    Bu, Xiao-Yun
    Chen, Huan-Wei
    Zhou, Yuan-Min
    Xu, Li
    Wei, Wei
    Zhang, Yao-Jun
    Chen, Min-Shan
    Guo, Rong-Ping
    Shi, Ming
    Li, Qi-Jiong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [4] Triple combination therapy of lenvatinib, toripalimab, and hepatic arterial infusion chemotherapy versus lenvatinib for advanced hepatocellular carcinoma
    Lai, Z-C.
    He, M-K.
    Shi, M.
    Li, Q-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1306 - S1306
  • [5] Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
    Ikeda, Masafumi
    Yamashita, Tatsuya
    Ogasawara, Sadahisa
    Kudo, Masatoshi
    Inaba, Yoshitaka
    Morimoto, Manabu
    Tsuchiya, Kaoru
    Shimizu, Satoshi
    Kojima, Yasushi
    Hiraoka, Atsushi
    Nouso, Kazuhiro
    Aikata, Hiroshi
    Numata, Kazushi
    Sato, Tosiya
    Okusaka, Takuji
    Furuse, Junji
    LIVER CANCER, 2024, 13 (02) : 193 - 202
  • [6] Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
    Ikeda, M.
    Yamashita, T.
    Ogasawara, S.
    Kudo, M.
    Inaba, Y.
    Morimoto, M.
    Tsuchiya, K.
    Shimizu, S.
    Kojima, Y.
    Hiraoka, A.
    Nouso, K.
    Aikata, H.
    Numata, K.
    Sato, T.
    Okusaka, T.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S821 - S822
  • [7] Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study
    Hao, Chunyi
    Du, Chengyou
    Peng, Baogang
    Zhang, Wu
    Shan, Yunfeng
    Lv, Ang
    Wu, Jianhui
    Shang, Changzhen
    Luo, Xuan
    Wei, Jinxing
    Xiao, Heng
    Qiu, Jianguo
    Hua, Yunpeng
    Shen, Shunli
    Wang, Ting
    Dai, Shengjie
    Chen, Xiang
    Yan, Shican
    Hao, Chunyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] Lenvatinib plus hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma.
    Yamamoto, Makoto
    Terashima, Takeshi
    Yamashita, Tatsuya
    Yanagi, Masahiro
    Nakagawa, Hidetoshi
    Seki, Akihiro
    Nio, Kouki
    Arai, Kuniaki
    Toyama, Tadashi
    Yamashita, Taro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 496 - 496
  • [9] Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
    Chen, Yajin
    Du, Chengyou
    Shen, Shunli
    Zhang, Wu
    Shan, Yunfeng
    Lyu, Ang
    Wu, Jianhui
    Shang, Changzhen
    Luo, Xuan
    Wei, Jinxing
    Xiao, Heng
    Qiu, Jianguo
    Hua, Yunpeng
    Wang, Shutong
    Wang, Ting
    Dai, Shengjie
    Zhang, Shuhao
    Xie, Bingying
    Wu, Yinghao
    Hao, Chunyi
    CLINICAL CANCER RESEARCH, 2024, 30 (14) : 2937 - 2944
  • [10] Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy
    Oh, Myung Jin
    Lee, Heon Ju
    Lee, Si Hyung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (03) : 288 - 299
12345